Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study. Article uri icon

Overview

authors

  • Perumal, Jai S.
  • Balabanov, Roumen
  • Su, Ray
  • Chang, Roger
  • Balcer, Laura
  • Galetta, Steven
  • Campagnolo, Denise I
  • Avila, Robin
  • Lee, Lily
  • Rutledge, Danette
  • Fox, Robert J

publication date

  • July 1, 2021

Identity

PubMed Central ID

  • PMC8280011

Scopus Document Identifier

  • 85108584180

Digital Object Identifier (DOI)

  • 10.1007/s12325-021-01815-6

PubMed ID

  • 34159559

Additional Document Info

volume

  • 38

issue

  • 7